UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 285

Sortiert nach

Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease

Atherosclerosis, 2008-03, Vol.197 (1), p.311-317

2008

Volltextzugriff (PDF)

Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual β-cell function: results from the PioSwitch Study

Diabetes, obesity & metabolism, 2009-05, Vol.11 (5), p.464-471

2009

Volltextzugriff (PDF)

Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis

Journal of cancer research and clinical oncology, 2003-03, Vol.129 (3), p.161-164

2003

Volltextzugriff (PDF)

Review of the pleiotropic effects of peroxisome proliferator-activated receptor gamma agonists on platelet function

Diabetes technology & therapeutics, 2007-10, Vol.9 (5), p.410

2007

Volltextzugriff (PDF)

The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight

Diabetes, obesity & metabolism, 2007-01, Vol.9 (1), p.132-133

2007

Volltextzugriff (PDF)

Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients

Hormone and metabolic research, 2009-03, Vol.41 (3), p.202

2009

Volltextzugriff (PDF)

Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours

Cancer Immunology, Immunotherapy, 1997-04, Vol.44 (2), p.88-96

1997

Volltextzugriff (PDF)

Serological and immunohistochemical HER-2/neu statuses do not correlate and lack prognostic value for ovarian cancer patients

European journal of cancer care, 2010-11, Vol.19 (6), p.809-815

2010

Volltextzugriff (PDF)

Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro

Cytokine (Philadelphia, Pa.), 2003-08, Vol.23 (4), p.119-125

2003

Volltextzugriff (PDF)

p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer

Journal of clinical pathology, 2001-11, Vol.54 (11), p.866-870

2001

Volltextzugriff (PDF)

PTCD1 Is Required for 16S rRNA Maturation Complex Stability and Mitochondrial Ribosome Assembly

Cell reports (Cambridge), 2018-04, Vol.23 (1), p.127-142

2018

Volltextzugriff (PDF)

Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients

European journal of clinical investigation, 2003-03, Vol.33 (3), p.256-260

2003

Volltextzugriff (PDF)

Weekly Carboplatin and Docetaxel for Locally Advanced Primary and Recurrent Cervical Cancer: A Phase I Study

Gynecologic oncology, 2002-10, Vol.87 (1), p.98-103

2002

Volltextzugriff (PDF)

The Choice of Reducing Substrate Is Altered by Replacement of an Alanine by a Proline in the FAD Domain of a Bispecific NAD(P)H-Nitrate Reductase from Birch

Plant physiology (Bethesda), 1995-05, Vol.108 (1), p.203-210

1995

Volltextzugriff (PDF)

Serological and immunohistochemical HER-2/neu statuses do not correlate and lack prognostic value for ovarian cancer patients: HER-2/neu and ovarian cancer

European journal of cancer care, 2010-11, Vol.19 (6), p.809-815

2010

Volltextzugriff (PDF)

In-frame length mutations associated with short tandem repeats are located in unassigned open reading frames of Oenothera chloroplast DNA

Current genetics, 1993-03, Vol.23 (3), p.265-270

1993

Volltextzugriff (PDF)

Increase in the degree of phosphorylation of circulating fibrinogen under thrombolytic therapy with urokinase

Thrombosis research, 1987-05, Vol.46 (3), p.437-445

1987

Volltextzugriff (PDF)

Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomas

Cancer letters, 1999-11, Vol.146 (2), p.195-199

1999

Volltextzugriff (PDF)

H-ras gene amplification or mutation is not common in human primary breast cancer

Oncology reports, 1999-09, Vol.6 (5), p.1029

1999

Volltextzugriff (PDF)

p21waf correlates with DNA replication but not with prognosis in invasive breast cancer

Journal of clinical pathology, 2001-11, Vol.54 (11), p.866-870

2001

Volltextzugriff (PDF)

The choice of reducting substrate is altered by replacement of an alanine by a proline in the FAD domain of a bispecific NAD(P)H-nitrate reductase from birch

Plant physiology (Bethesda), 1995, Vol.108 (1), p.203-210

1995

Volltextzugriff (PDF)

Modified “low-dose” heparin prophylaxis to reduce thrombosis after hip joint operations

Thrombosis research, 1978, Vol.12 (1), p.153-163

1978

Volltextzugriff (PDF)

Immunohistochemical Detection of H-ras Protooncoprotein p21 Indicates Favorable Prognosis in Node-Negative Breast Cancer Patients

Tumor biology, 1999-07, Vol.20 (4), p.173-183

1999

Volltextzugriff (PDF)

Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride

Metabolism, clinical and experimental, 2006, Vol.55 (1), p.20-25

2006

Volltextzugriff (PDF)

Alterations of antithrombin III after acute myocardial infarction

Folia haematologica (Leipzig, Germany : 1928), 1988, Vol.115 (3), p.319

1988

Volltextzugriff (PDF)

1 – 25 von 285

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

KollektionProQuest Dissertations & Theses A&I

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(214)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease

Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual β-cell function: results from the PioSwitch Study

Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis

Review of the pleiotropic effects of peroxisome proliferator-activated receptor gamma agonists on platelet function

The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight

Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients

Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours

Serological and immunohistochemical HER-2/neu statuses do not correlate and lack prognostic value for ovarian cancer patients

Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro

p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer

PTCD1 Is Required for 16S rRNA Maturation Complex Stability and Mitochondrial Ribosome Assembly

Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients

Weekly Carboplatin and Docetaxel for Locally Advanced Primary and Recurrent Cervical Cancer: A Phase I Study

The Choice of Reducing Substrate Is Altered by Replacement of an Alanine by a Proline in the FAD Domain of a Bispecific NAD(P)H-Nitrate Reductase from Birch

Serological and immunohistochemical HER-2/neu statuses do not correlate and lack prognostic value for ovarian cancer patients: HER-2/neu and ovarian cancer

In-frame length mutations associated with short tandem repeats are located in unassigned open reading frames of Oenothera chloroplast DNA

Increase in the degree of phosphorylation of circulating fibrinogen under thrombolytic therapy with urokinase

Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomas

H-ras gene amplification or mutation is not common in human primary breast cancer

p21waf correlates with DNA replication but not with prognosis in invasive breast cancer

The choice of reducting substrate is altered by replacement of an alanine by a proline in the FAD domain of a bispecific NAD(P)H-nitrate reductase from birch

Modified “low-dose” heparin prophylaxis to reduce thrombosis after hip joint operations

Immunohistochemical Detection of H-ras Protooncoprotein p21 Indicates Favorable Prognosis in Node-Negative Breast Cancer Patients

Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride

Alterations of antithrombin III after acute myocardial infarction

Aktive Filter

Suchergebnisse filtern